Niva WealthLet’s talk

Royalty Pharma Manager

SEC-registered adviser since 2025New York, NYCRD 334982

$18.5B
AUM
2
Clients
See fees
Fee
48
Advisory staff

From Form ADV filed 31 March 2026 · data retrieved 15 October 2026SEC record

Royalty Pharma Manager is an investment adviser headquartered in New York, New York, and registered with the SEC since 2025. Its clients include pooled investment vehicles.

Its services include portfolio management for pooled vehicles. Fee arrangements include a percentage of assets under management, fixed fees, performance-based fees and other arrangements. Royalty Pharma Holdings LTD owns 75% or more of Royalty Pharma Manager, and Pablo Legorreta is its CEO.

Clients

Royalty Pharma Manager serves 2 clients. The average client has about $9.27 billion with the firm.

Regulatory assets by client type
  • Pooled investment vehicles2 clients100%
Show client breakdown
Pooled investment vehicles
Clients
2
Regulatory AUM
$18,541,246,135
Share
100.0%
Avg. per client
$9.27B

Total

Clients
2
Regulatory AUM
$18,541,246,135
Share
100%
Avg. per client
$9.27B

What it does

Royalty Pharma Manager provides portfolio management for pooled vehicles. It is paid through a percentage of assets, fixed fees, performance-based fees and other arrangements.

Royalty Pharma Manager provided financial planning to 0 clients last fiscal year and advises no private funds.

100.0% of assets ($18.54B across 2 accounts) are managed with discretion. 100% of clients are outside the U.S., and 0 clients received advice without assets under management last fiscal year.

Custodians

Royalty Pharma Manager has custody of client assets.

Managed account assets by custodian
  • All other custodians$18.54B100%

Ownership and leadership

Royalty Pharma Holdings LTD owns 75% or more of Royalty Pharma Manager, and Pablo Legorreta is its CEO.

Who owns the firm
Royalty Pharma Manager, LLC· the adviser

  • Royalty Pharma Holdings LTD

    Control person · since May 2025

    Owns 75% or more of Royalty Pharma Manager, LLC

Leadership

  • Pablo Legorreta
    Chief Executive Officer
  • Terrance Coyne
    Executive Vice President and Chief Financial Officer
  • Carolyn Rubin
    Executive Vice President and Chief Compliance Officer
  • Arthur McGivern
    General Counsel

Staff

  • 91 employees
  • 48 in advisory functions

Fees

Royalty Pharma Manager is paid through a percentage of assets under management, fixed fees (other than subscription fees), performance-based fees and other.

Royalty Pharma Manager’s fee rates are not included in this profile. Find its brochure on the SEC’s site.

Offices and registrations

Besides its headquarters, Royalty Pharma Manager has 0 offices, with 1 listed address in 1 state.

Listed office addresses by state

New York · 1 listed address

  • 110 East 59th Street, New YorkHQ

Registration details

Legal name
Royalty Pharma Manager, LLC
Headquarters
110 East 59th Street, New York, NY 10022
Phone
212-883-0200
Website
royaltypharma.com
SEC file
801-132132
Structure
Delaware LLC
Fiscal year end
December

This directory does not report disciplinary history, for any firm or individual, in either direction. The SEC publishes the complete record, including any disciplinary events, and it is the authoritative place to check one. See this firm's record on adviserinfo.sec.gov

Common questions

How many clients does Royalty Pharma Manager have?

Royalty Pharma Manager has 2 clients and manages $18.5 billion for them, as of March 2026.

Source: Form ADV Part 1A, Items 5.D and 5.F, filed 31 March 2026

What services does Royalty Pharma Manager offer?

Royalty Pharma Manager provides portfolio management for pooled vehicles.

Source: Form ADV Part 1A, Item 5.G, from the SEC's 2 October 2026 data file

How many financial advisors does Royalty Pharma Manager have?

Royalty Pharma Manager has 0 investment adviser representatives registered with state securities authorities, out of 91 employees, and 48 perform investment advisory functions. None are registered representatives of a broker-dealer or licensed insurance agents.

Source: Form ADV Part 1A, Items 5.A and 5.B, from the SEC's 2 October 2026 data file

Who owns Royalty Pharma Manager?

Royalty Pharma Manager is owned through a holding company by Royalty Pharma PLC. Its direct owner is Royalty Pharma Holdings LTD (75% or more).

Source: Form ADV Part 1A, Schedules A and B, filed 31 March 2026

How does Royalty Pharma Manager get paid?

Royalty Pharma Manager is paid through a percentage of assets under management, fixed fees, performance-based fees and other arrangements. Its Form ADV lists no commissions among how it is paid.

Source: Form ADV Part 1A, Item 5.E, from the SEC's 2 October 2026 data file

Sources

  1. Form ADV Part 1A, amendment filed 31 March 2026. Items 1, 5, 9, 11 and Schedules A, B and D.
  2. IAPD firm record, CRD 334982.

Retrieved 15 October 2026. All are published by the SEC and may have been amended since.

Download source data (JSON)How this directory is compiledReport a correction

This profile is compiled from public regulatory filings and is provided for informational purposes only. Niva Wealth is not affiliated with Royalty Pharma Manager, LLC and makes no representation about the quality of its services. Figures reflect the filing dates shown and may have changed. Ownership percentages are the bands reported to the SEC, not exact figures.